Responsibility for the Danish market
Under the direction of the Nordic Business Unit Director, you will have full responsibility for the Danish market. This includes support for and contact with public and private fertility clinics in Denmark, as well as influencing Key Opinion Leaders.
You will participate in strategizing and implementation of relevant marketing activities, including congresses and workshops with doctors and nurses – when it comes to ethically correct information about current products (Menopur and Rekovelle), but also for the introduction of new products.
You will be part of a strong Nordic team and you will get product and commercial support from a very competent organisation.
The right background
The ideal KAM has a relevant higher education, supplemented with a some of sales experience from a similar position – preferably in the area of maternal health.
You are familiar with the special ethical issues in the field, but also the life-affirming and positive aspects of helping families.
As a person, you are very trustworthy and reliable, results-oriented and systematic in your work. You master English and are used to modern IT and CRM systems.
We can offer our next KAM an exciting position in one of the absolute leading companies in the field, a strong product portfolio and an exciting pipeline. You will have the backing of a competent organisation that is ready to assist you and your customers.
You will be part of a company that offers excellent personal and professional challenges – with a salary package that reflects the demands of the job.
If you have any questions, you are welcome to contact John Wagner at People Capital Partner on tel. + 45 3024 2409 or at firstname.lastname@example.org
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets and has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries. Ferring has evolved and grown since Frederik and Eva Paulsen founded the company in Malmö, Sweden in the 1950s. The team is built on a pioneering spirit and a drive to create life-changing treatments for people that need them. Today the headquarter is in Saint-Prex, Switzerland.
Ferring employs over 6,000 people across countries and the diversity of our team brings exciting ideas and innovation. By working together, we can apply new science to unmet needs to help people live better lives. Ferring is committed to supporting all employees in their career development and to ensuring all our team members receive the right level of support and progression. Ferring has R&D centers in Brazil, China, Denmark, India, Israel, Japan, Russia, Switzerland, the UK and two in the US. The main pharmaceutical development hub is in Copenhagen. The Copenhagen and Parsippany sites drive and execute product innovation and development of new molecular entities as well as further development of our existing in-line products to better meet patient needs or address new disease areas.
Ferring has manufacturing sites in 13 countries. In-house production is carried out in Argentina, China, the Czech Republic, Denmark, Germany, India, Israel, Mexico, Switzerland, the UK, and the US